Stay updated on Pembrolizumab in Hypermutation Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Hypermutation Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Hypermutation Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.3.3, and the previous Revision: v3.3.2 and the HHS Vulnerability Disclosure text have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T10:14:20.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    35 days ago
    Change Detected
    Summary
    The changes update the Publications section wording to indicate that PubMed-listed publications are automatically populated from PubMed, and note the revision version. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T17:39:36.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    A government funding/status notice at the top of the page was removed. This change does not affect the study content, eligibility criteria, or results of the trial. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T17:23:52.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The updated screenshots show cosmetic UI adjustments with no changes to core trial information (status, enrollment, eligibility, outcomes). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T09:51:51.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Adds a current operating-status notice, a verified status entry with a date, and a new revision (v3.2.0); removes the old status and previous revision (v3.1.0).
    Difference
    3%
    Check dated 2025-10-05T14:22:57.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.
    Difference
    0.1%
    Check dated 2025-09-28T09:46:56.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Hypermutation Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Hypermutation Clinical Trial page.